Literature DB >> 28421441

N-methyl serotonin analogues from the Bufo bufo toad venom interact efficiently with the α7 nicotinic acetylcholine receptors.

E V Kryukova1, D S Lebedev2, I A Ivanov2, D A Ivanov2, V G Starkov2, V I Tsetlin2, Yu N Utkin2.   

Abstract

Two low-molecular-weight compounds were isolated from the parotid gland secret of the toad Bufo bufo, which by absorption spectra and HPLC-MS/MS chromatography data correspond to di- and trimethyl derivatives of serotonin (5-hydorxytryptamine): bufotenine (confirmed by counter synthesis) and bufotenidine (5-HTQ). In experiments on competitive radioligand binding, these compounds showed a higher affinity and selectivity for neuronal α7 nicotinic acetylcholine receptors compared with the muscular cholinergic receptors. The most efficient compound in terms of binding value was bufotenine, the efficiency of 5-HTQ was an order of magnitude lower, and the minimal activity was exhibited by serotonin.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28421441     DOI: 10.1134/S1607672917010136

Source DB:  PubMed          Journal:  Dokl Biochem Biophys        ISSN: 1607-6729            Impact factor:   0.788


  12 in total

Review 1.  α7 nicotinic acetylcholine receptors in Alzheimer's disease: neuroprotective, neurotrophic or both?

Authors:  Caterina M Hernandez; Kelly T Dineley
Journal:  Curr Drug Targets       Date:  2012-05       Impact factor: 3.465

Review 2.  Nicotinic acetylcholine receptors: from basic science to therapeutics.

Authors:  Raymond Hurst; Hans Rollema; Daniel Bertrand
Journal:  Pharmacol Ther       Date:  2012-08-25       Impact factor: 12.310

3.  Development of a LC-MS/MS method to analyze 5-methoxy-N,N-dimethyltryptamine and bufotenine, and application to pharmacokinetic study.

Authors:  Hong-Wu Shen; Xi-Ling Jiang; Ai-Ming Yu
Journal:  Bioanalysis       Date:  2009-04       Impact factor: 2.681

4.  Serotonin antagonizes the human neuronal alpha7 nicotinic acetylcholine receptor and becomes an agonist after L248T alpha7 mutation.

Authors:  S Fucile; E Palma; F Eusebi; R Miledi
Journal:  Neuroscience       Date:  2002       Impact factor: 3.590

5.  Relative activities of substances related to 5-hydroxytryptamine as depolarizing agents of superior cervical ganglion cells.

Authors:  D Wallis; H Nash
Journal:  Eur J Pharmacol       Date:  1981-03-26       Impact factor: 4.432

Review 6.  Unconventional ligands and modulators of nicotinic receptors.

Authors:  Edna F R Pereira; Corey Hilmas; Mariton D Santos; Manickavasagom Alkondon; Alfred Maelicke; Edson X Albuquerque
Journal:  J Neurobiol       Date:  2002-12

Review 7.  Assembly of nicotinic and other Cys-loop receptors.

Authors:  Victor Tsetlin; Dmitry Kuzmin; Igor Kasheverov
Journal:  J Neurochem       Date:  2011-01-13       Impact factor: 5.372

8.  Enhancement by 5-hydroxytryptamine and analogues of desensitization of neuronal and muscle nicotinic receptors expressed in Xenopus oocytes.

Authors:  K M Cross; R C Foreman; J E Chad
Journal:  Br J Pharmacol       Date:  1995-04       Impact factor: 8.739

9.  Block by 5-hydroxytryptamine of neuronal acetylcholine receptor channels expressed in Xenopus oocytes.

Authors:  K Nakazawa; T Akiyama; K Inoue
Journal:  Cell Mol Neurobiol       Date:  1995-08       Impact factor: 5.046

10.  Bufotenine is able to block rabies virus infection in BHK-21 cells.

Authors:  Hugo Vigerelli; Juliana Mozer Sciani; Carlos Jared; Marta Maria Antoniazzi; Graciane Maria Medeiros Caporale; Andréa de Cássia Rodrigues da Silva; Daniel C Pimenta
Journal:  J Venom Anim Toxins Incl Trop Dis       Date:  2014-10-13
View more
  2 in total

1.  Chemical and Pharmacological Screening of Rhinella icterica (Spix 1824) Toad Parotoid Secretion in Avian Preparations.

Authors:  Raquel Soares Oliveira; Bruna Trindade Borges; Allan Pinto Leal; Manuela Merlin Lailowski; Karla de Castro Figueiredo Bordon; Velci Queiróz de Souza; Lúcia Vinadé; Tiago Gomes Dos Santos; Stephen Hyslop; Sidnei Moura; Eliane Candiani Arantes; Alexandre Pinto Corrado; Cháriston A Dal Belo
Journal:  Toxins (Basel)       Date:  2020-06-15       Impact factor: 4.546

Review 2.  The Development of Toad Toxins as Potential Therapeutic Agents.

Authors:  Ji Qi; Abu Hasanat Md Zulfiker; Chun Li; David Good; Ming Q Wei
Journal:  Toxins (Basel)       Date:  2018-08-20       Impact factor: 4.546

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.